Abbott Matthew S 4
4 · Chemours Co · Filed May 10, 2024
Insider Transaction Report
Form 4
Abbott Matthew S
VP, CAO & Controller
Transactions
- Award
Stock Option (Right to Buy)
2024-05-08+31,614→ 31,614 totalExercise: $27.50Exp: 2034-05-08→ Common Stock (31,614 underlying) - Award
Performance Stock Option (Right to Buy)
2024-05-08+32,879→ 32,879 totalExercise: $30.25Exp: 2034-05-08→ Common Stock (32,879 underlying) - Award
Common Stock
2024-05-08+11,818→ 46,106.225 total
Footnotes (4)
- [F1]Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2025.
- [F2]Includes directly owned shares, restricted stock units and dividend equivalent units.
- [F3]These options are scheduled to vest in three equal annual installments beginning on May 8, 2025.
- [F4]Represents a 10 percent premium above the closing price of the Company common stock on the date of grant.